Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

3840 - Optimal extent of abdominal lymph node dissection for advanced Siewert type II and III esophagogastric junction carcinoma


09 Sep 2017


Poster display session


Surgical Oncology;  Radiation Oncology;  Oesophageal Cancer;  Gastric Cancer


Jian-Xian Lin


Annals of Oncology (2017) 28 (suppl_5): v209-v268. 10.1093/annonc/mdx369


J. Lin, H. Chang-Ming, C. Zheng, P. Li, J. Xie

Author affiliations

  • Department Of Gastric Surgery, Fujian Medical University Union Hospital, 350001 - Fuzhou/CN


Abstract 3840


The aim of this study was to clarify the optimal abdominal lymphadenectomy for advanced in Siewert types II and III adenocarcinoma of the esophagogastric junction (AEG).


From June 2007 to June 2014, the data of 573 patients who underwent radical total gastrectomy due to advanced Siewert types II and III was collected and retrospectively analyzed. The incidence of abdominal lymph node metastasis (LNM) of each station were compared between patients with Siewert type II and III AEG. And we used the therapeutic index to assess the efficacy of abdominal lymph node dissection of each station.


Of the 573 patients, 247 (44.0%) had Siewert type II AEG and 326 (56.0%) had type III AEG. Among them, 252 patients carried out abdominal D2 lymphadenectomy and 321 patients underwent D2 lymphadenectomy without No. 10 lymphadenectomy (D2-). The mean number of dissected LNs was 34.6±13.0, and the numbers of dissected lymph nodes at each lymph node station did not significantly differ between patients with type II and III AEG (P > 0.05). The therapeutic index of No.1-3, 7, 9 and 11 LNs was over 4.0 in advanced type II AEG cases, while the index was higher than 4.0 in No.1-4 and 7-11 LNs in patients with type III AEG. The index of No.10 LNs was more than 10 in type III AEG subgroups with primary tumors invading the serosa layer (15.6), undifferentiated cancers (10.9) and tumor size ≥50mm (10.5).


Dissection of No. 1-3, 7, 9 and 11 LNs would obtain highest survival benefits regardless of the Siewert subtype. Patients with type AEG, especially those with primary tumors invading the serosa layer, undifferentiated cancers and tumor size ≥50mm might obtain relatively higher survival benefits from No. 10 lymphadenectomy.

Clinical trial identification

Legal entity responsible for the study

Changming Huang




All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.